Amgen Inc. (AMGN) SVP exercises options and sells 3,890 shares
Rhea-AI Filing Summary
Amgen Inc. executive Derek Miller, SVP of Human Resources, exercised stock options for a total of 3,890 shares of common stock on August 6, 2026, at strike prices of $162.60 and $177.46 per share. He then sold 3,890 common shares at a weighted-average price of $402.5444 per share in open market or private transactions. Footnotes state these sales include shares used to cover the option exercise price and required withholding taxes, and separately describe 117 dividend equivalents credited to unvested restricted stock units under Amgen's equity incentive plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 3,890 shares ($906K approx. pre-tax spread)
Exercise and Sale
6 txns
Insider
Miller Derek
Role
SVP, Human Resources
Sold
3,890 shs ($1.57M)
Approx. gross sale proceeds
$1.57M
Approx. exercise cost
$660K
Approx. pre-tax spread
$906K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Nqso (Right to Buy) | 2,069 | $0.00 | $0.00 |
| Exercise | Nqso (Right to Buy) | 1,821 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,069 | $162.60 | $336K |
| Sale | Common Stock F1, F2 | 2,069 | $402.5444 | $833K |
| Exercise | Common Stock | 1,821 | $177.46 | $323K |
| Sale | Common Stock F1, F2, F3 | 1,821 | $402.5444 | $733K |
Holdings After Transaction:
Nqso (Right to Buy) — 0 shares (Direct);
Common Stock — 12,462 shares (Direct)
Footnotes (3)
- F1. Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options.
- F2. The price reported is an average price of $402.5444 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- F3. These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Key Figures
Options Exercised: 3,890 shares
Exercise Price 1: $162.6000 per share
Exercise Price 2: $177.4600 per share
+3 more
6 metrics
Options Exercised
3,890 shares
Total NQSO shares exercised on 2026-08-06
Exercise Price 1
$162.6000 per share
Strike price for 2,069 NQSO shares exercised
Exercise Price 2
$177.4600 per share
Strike price for 1,821 NQSO shares exercised
Shares Sold
3,890 shares
Common stock sold following option exercises on 2026-08-06
Average Sale Price
$402.5444 per share
Weighted-average price for the reported sales
Dividend Equivalents
117
DEs credited to unvested RSUs under Amgen’s 2009 Equity Incentive Plan
Key Terms
Nqso (Right to Buy), Dividend Equivalents (DEs), Restricted Stock Units, qualifying dividend reinvestment plan
4 terms
Nqso (Right to Buy) financial
"security_title: Nqso (Right to Buy) with underlying Amgen common stock"
Dividend Equivalents (DEs) financial
"These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. plan"
Restricted Stock Units financial
"DEs are credited to the reporting person's unvested Restricted Stock Units and paid in shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
qualifying dividend reinvestment plan financial
"DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Derek Miller report for AMGN on August 6, 2026?
Derek Miller reported exercising stock options for 3,890 Amgen shares and selling the same 3,890 common shares on August 6, 2026. The sales followed option exercises at lower strike prices and were executed at an average price of $402.5444 per share.
How many Amgen (AMGN) stock options did Derek Miller exercise and at what strike prices?
He exercised nonqualified stock options covering 2,069 shares at a strike price of $162.60 and another 1,821 shares at $177.46. These option exercises converted the derivatives into equivalent shares of Amgen common stock before the reported sales.
What are the 117 Dividend Equivalents mentioned in Derek Miller’s AMGN filing?
The filing notes that certain reported shares include 117 Dividend Equivalents (DEs) granted under Amgen’s 2009 Equity Incentive Plan. These DEs are credited to unvested restricted stock units and are paid out in Amgen common stock on a one-to-one basis as the RSUs vest.